| Year |
Citation |
Score |
| 2023 |
Kang B, Zhang J, Schwoerer MP, Nelson AN, Schoeman E, Ploss A, Myhrvold C. Highly multiplexed mRNA quantitation with CRISPR-Cas13. Biorxiv : the Preprint Server For Biology. PMID 37645785 DOI: 10.1101/2023.08.16.553527 |
0.735 |
|
| 2023 |
Maya S, Hershkovich L, Cardozo-Ojeda EF, Shirvani-Dastgerdi E, Srinivas J, Shekhtman L, Uprichard SL, Berneshawi AR, Cafiero TR, Dahari H, Ploss A. Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic. Mbio. e0100823. PMID 37436080 DOI: 10.1128/mbio.01008-23 |
0.355 |
|
| 2023 |
Hogan G, Winer BY, Ahodantin J, Sellau J, Huang T, Douam F, Funaki M, Chiriboga L, Su L, Ploss A. Persistent hepatitis B virus and HIV coinfections in dually humanized mice engrafted with human liver and immune system. Journal of Medical Virology. 95: e28930. PMID 37403703 DOI: 10.1002/jmv.28930 |
0.363 |
|
| 2023 |
Liu Y, Cafiero TR, Park D, Biswas A, Winer BY, Cho CH, Bram Y, Chandar V, Connell AKO, Gertje HP, Crossland N, Schwartz RE, Ploss A. Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells. Nature Communications. 14: 3582. PMID 37328459 DOI: 10.1038/s41467-023-39148-3 |
0.361 |
|
| 2023 |
Maya S, Hershkovich L, Cardozo-Ojeda EF, Shirvani-Dastgerdi E, Srinivas J, Shekhtman L, Uprichard SL, Berneshawi AR, Cafiero TR, Dahari H, Ploss A. Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic. Biorxiv : the Preprint Server For Biology. PMID 36824865 DOI: 10.1101/2023.02.17.528964 |
0.368 |
|
| 2022 |
Schwoerer MP, Ploss A. Barriers to hepatitis C virus infection in mice. Current Opinion in Virology. 56: 101273. PMID 36244239 DOI: 10.1016/j.coviro.2022.101273 |
0.814 |
|
| 2022 |
Wei L, Cafiero TR, Tseng A, Gertje HP, Berneshawi A, Crossland NA, Ploss A. Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells. Jhep Reports : Innovation in Hepatology. 4: 100534. PMID 36035363 DOI: 10.1016/j.jhepr.2022.100534 |
0.305 |
|
| 2022 |
Liu Y, Park D, Cafiero TR, Bram Y, Chandar V, Tseng A, Gertje HP, Crossland NA, Su L, Schwartz RE, Ploss A. Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses. Jhep Reports : Innovation in Hepatology. 4: 100535. PMID 36035359 DOI: 10.1016/j.jhepr.2022.100535 |
0.339 |
|
| 2022 |
Biswas S, Rust LN, Wettengel JM, Yusova S, Fischer M, Carson JN, Johnson J, Wei L, Thode T, Kaadige MR, Sharma S, Agbaria M, Bimber BN, Tu T, Protzer U, ... Ploss A, et al. Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity. Nature Communications. 13: 2995. PMID 35637225 DOI: 10.1038/s41467-022-30593-0 |
0.339 |
|
| 2022 |
Buksh BF, Knutson SD, Oakley JV, Bissonnette NB, Oblinsky DG, Schwoerer MP, Seath CP, Geri JB, Rodriguez-Rivera FP, Parker DL, Scholes GD, Ploss A, MacMillan DWC. μMap-Red: Proximity Labeling by Red Light Photocatalysis. Journal of the American Chemical Society. 144: 6154-6162. PMID 35363468 DOI: 10.1021/jacs.2c01384 |
0.727 |
|
| 2021 |
Zakh R, Churkin A, Bietsch W, Lachiany M, Cotler SJ, Ploss A, Dahari H, Barash D. A Mathematical Model for early HBV and -HDV Kinetics during Anti-HDV Treatment. Mathematics (Basel, Switzerland). 9. PMID 35282153 DOI: 10.3390/math9243323 |
0.328 |
|
| 2021 |
Tamura T, Zhang J, Madan V, Biswas A, Schwoerer MP, Cafiero TR, Heller BL, Wang W, Ploss A. Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1-4. Emerging Microbes & Infections. 1-43. PMID 34931940 DOI: 10.1080/22221751.2021.2021808 |
0.771 |
|
| 2021 |
Wei L, Ploss A. Mechanism of Hepatitis B Virus cccDNA Formation. Viruses. 13. PMID 34452329 DOI: 10.3390/v13081463 |
0.324 |
|
| 2021 |
Liu Y, Maya S, Ploss A. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Viruses. 13. PMID 33924793 DOI: 10.3390/v13050777 |
0.347 |
|
| 2020 |
Brown RJP, Tegtmeyer B, Sheldon J, Khera T, Anggakusuma, Todt D, Vieyres G, Weller R, Joecks S, Zhang Y, Sake S, Bankwitz D, Welsch K, Ginkel C, Engelmann M, ... ... Ploss A, et al. Liver-expressed and limit hepatitis C virus cross-species transmission to mice. Science Advances. 6. PMID 33148654 DOI: 10.1126/sciadv.abd3233 |
0.617 |
|
| 2020 |
Berggren KA, Suzuki S, Ploss A. Animal Models Used in Hepatitis C Virus Research. International Journal of Molecular Sciences. 21. PMID 32485887 DOI: 10.3390/Ijms21113869 |
0.576 |
|
| 2020 |
Berggren KA, Suzuki S, Ploss A. Animal Models Used in Hepatitis C Virus Research. International Journal of Molecular Sciences. 21. PMID 32485887 DOI: 10.3390/ijms21113869 |
0.495 |
|
| 2020 |
Ramanathan HN, Zhang S, Douam F, Mar KB, Chang J, Yang PL, Schoggins JW, Ploss A, Lindenbach BD. A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating. Mbio. 11. PMID 32291299 DOI: 10.1128/Mbio.00467-20 |
0.66 |
|
| 2020 |
Wei L, Ploss A. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation. Nature Microbiology. PMID 32152586 DOI: 10.1038/S41564-020-0678-0 |
0.383 |
|
| 2020 |
Chen CY, Winer BY, Chavez D, Guerra B, Brasky KM, Eng S, Salas E, Tam D, Simmons JH, Abee CR, Delaney WE, Ploss A, Lanford RE, Voitenleitner C. Woolly Monkey-HBV Infection in Squirrel Monkeys as a Surrogate Nonhuman Primate Model of HBV Infection. Hepatology Communications. 4: 371-386. PMID 32140655 DOI: 10.1002/hep4.1471 |
0.338 |
|
| 2020 |
Winer B, Edgel KA, Zou X, Sellau J, Hadiwidjojo S, Garver LS, McDonough CE, Kelleher NL, Thomas PM, Villasante E, Ploss A, Gerbasi VR. Identification of Plasmodium falciparum proteoforms from liver stage models. Malaria Journal. 19: 10. PMID 31910830 DOI: 10.1186/S12936-019-3093-3 |
0.333 |
|
| 2019 |
Akkina R, Barber DL, Bility MT, Bissig KD, Burwitz BJ, Eichelberg K, Endsley JJ, Garcia JV, Hafner R, Karakousis PC, Korba BE, Koshy R, Lambros C, Menne S, Nuermberger EL, ... Ploss A, et al. Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop. Current Hiv Research. PMID 31870268 DOI: 10.2174/1570162X18666191223114019 |
0.384 |
|
| 2019 |
Ploss A, Kapoor A. Animal Models of Hepatitis C Virus Infection. Cold Spring Harbor Perspectives in Medicine. PMID 31843875 DOI: 10.1101/Cshperspect.A036970 |
0.564 |
|
| 2019 |
Maya S, Ploss A. Master of disguise: hepatitis delta virus packaging and spread facilitated by diverse viral envelope proteins. Hepatology (Baltimore, Md.). PMID 31465549 DOI: 10.1002/Hep.30922 |
0.506 |
|
| 2019 |
LeDesma R, Nimgaonkar I, Ploss A. Hepatitis E Virus Replication. Viruses. 11. PMID 31390784 DOI: 10.3390/V11080719 |
0.424 |
|
| 2019 |
Winer BY, Gaska JM, Lipkowitz G, Bram Y, Parekh A, Parsons L, Leach R, Jindal R, Cho CH, Shrirao A, Novik E, Schwartz RE, Ploss A. Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system. Hepatology (Baltimore, Md.). PMID 31206195 DOI: 10.1002/Hep.30815 |
0.493 |
|
| 2019 |
Gaska JM, Balev M, Ding Q, Heller B, Ploss A. Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus. Elife. 8. PMID 31074414 DOI: 10.7554/Elife.44436 |
0.56 |
|
| 2019 |
Mesev EV, LeDesma RA, Ploss A. Decoding type I and III interferon signalling during viral infection. Nature Microbiology. PMID 30936491 DOI: 10.1038/S41564-019-0421-X |
0.387 |
|
| 2019 |
Gaska JM, Ding Q, Ploss A. Mouse Models for Studying HCV Vaccines and Therapeutic Antibodies. Methods in Molecular Biology (Clifton, N.J.). 1911: 481-503. PMID 30593647 DOI: 10.1007/978-1-4939-8976-8_33 |
0.524 |
|
| 2019 |
Gaska JM, Balev M, Ding Q, Heller B, Ploss A. Author response: Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus Elife. DOI: 10.7554/Elife.44436.022 |
0.451 |
|
| 2018 |
Douam F, Ziegler CGK, Hrebikova G, Fant B, Leach R, Parsons L, Wang W, Gaska JM, Winer BY, Heller B, Shalek AK, Ploss A. Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses. Nature Communications. 9: 5031. PMID 30487575 DOI: 10.1038/S41467-018-07478-2 |
0.371 |
|
| 2018 |
Winer BY, Shirvani-Dastgerdi E, Bram Y, Sellau J, Low BE, Johnson H, Huang T, Hrebikova G, Heller B, Sharon Y, Giersch K, Gerges S, Seneca K, Pais MA, Frankel AS, ... ... Ploss A, et al. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Science Translational Medicine. 10. PMID 29950446 DOI: 10.1126/Scitranslmed.Aap9328 |
0.513 |
|
| 2018 |
Douam F, Ploss A. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe. Trends in Microbiology. PMID 29933925 DOI: 10.1016/J.Tim.2018.05.012 |
0.344 |
|
| 2018 |
Ding Q, Gaska JM, Douam F, Wei L, Kim D, Balev M, Heller B, Ploss A. Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease. Proceedings of the National Academy of Sciences of the United States of America. PMID 29915078 DOI: 10.1073/Pnas.1803406115 |
0.493 |
|
| 2018 |
Ding Q, Nimgaonkar I, Archer NF, Bram Y, Heller B, Schwartz RE, Ploss A. Identification of the Intragenomic Promoter Controlling Hepatitis E Virus Subgenomic RNA Transcription. Mbio. 9. PMID 29739903 DOI: 10.1128/Mbio.00769-18 |
0.39 |
|
| 2018 |
Dragovic SM, Agunbiade TA, Freudzon M, Yang J, Hastings AK, Schleicher TR, Zhou X, Craft S, Chuang YM, Gonzalez F, Li Y, Hrebikova G, Tripathi A, Mlambo G, Almeras L, ... Ploss A, et al. Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice. Cell Host & Microbe. 23: 523-535.e5. PMID 29649443 DOI: 10.1016/J.Chom.2018.03.008 |
0.375 |
|
| 2018 |
Douam F, Ploss A. The use of humanized mice for studies of viral pathogenesis and immunity. Current Opinion in Virology. 29: 62-71. PMID 29604551 DOI: 10.1016/J.Coviro.2018.03.003 |
0.402 |
|
| 2018 |
Douam F, Fusil F, Enguehard M, Dib L, Nadalin F, Schwaller L, Hrebikova G, Mancip J, Mailly L, Montserret R, Ding Q, Maisse C, Carlot E, Xu K, Verhoeyen E, ... ... Ploss A, et al. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. Plos Pathogens. 14: e1006908. PMID 29505618 DOI: 10.1371/Journal.Ppat.1006908 |
0.528 |
|
| 2018 |
Winer BY, Parekh A, Heller B, Lipkowitz G, Guo R, Cho C, Shrirao A, Pludwinski E, Novik E, Ploss A. Persistent Hepatitis B virus infection in self-assembling microscale primary hepatocyte co-culture Drug Metabolism and Pharmacokinetics. 33: S59-S60. DOI: 10.1016/J.Dmpk.2017.11.201 |
0.401 |
|
| 2017 |
Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nature Reviews. Gastroenterology & Hepatology. PMID 29162935 DOI: 10.1038/Nrgastro.2017.150 |
0.441 |
|
| 2017 |
Nimgaonkar I, Ploss A. A porcine model for chronic hepatitis E. Hepatology (Baltimore, Md.). PMID 28961321 DOI: 10.1002/Hep.29566 |
0.34 |
|
| 2017 |
Douam F, Soto Albrecht YE, Hrebikova G, Sadimin E, Davidson C, Kotenko SV, Ploss A. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo. Mbio. 8. PMID 28811340 DOI: 10.1128/Mbio.00819-17 |
0.405 |
|
| 2017 |
Winer BY, Huang TS, Pludwinski E, Heller B, Wojcik F, Lipkowitz GE, Parekh A, Cho C, Shrirao A, Muir TW, Novik E, Ploss A. Long-term hepatitis B infection in a scalable hepatic co-culture system. Nature Communications. 8: 125. PMID 28743900 DOI: 10.1038/S41467-017-00200-8 |
0.475 |
|
| 2017 |
Li D, Wang X, von Schaewen M, Tao W, Zhang Y, Heller B, Hrebikova G, Deng Q, Sun Q, Ploss A, Zhong J, Huang Z. Immunization with a subunit hepatitis C virus vaccine elicits pan-genotypic neutralizing antibodies and intra-hepatic T-cell responses in non-human primates. The Journal of Infectious Diseases. PMID 28398489 DOI: 10.1093/Infdis/Jix180 |
0.528 |
|
| 2017 |
Shirvani-Dastgerdi E, Winer BY, Celia-Terrassa A, Kang Y, Tabernero D, Yagmur E, Rodríguez-Frías F, Gregori J, Luedde T, Trautwein C, Ploss A, Tacke F. Selection of the highly replicative and partially multidrug resistant rtS78T polymerase mutation in two patients with chronic hepatitis B virus infection during tenofovir-entecavir combination therapy. Journal of Hepatology. PMID 28392234 DOI: 10.1016/J.Jhep.2017.03.027 |
0.388 |
|
| 2017 |
Douam F, Hrebikova G, Albrecht YE, Sellau J, Sharon Y, Ding Q, Ploss A. Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome. Nature Communications. 8: 14781. PMID 28290449 DOI: 10.1038/Ncomms14781 |
0.42 |
|
| 2017 |
Ding Q, Heller B, Capuccino JM, Song B, Nimgaonkar I, Hrebikova G, Contreras JE, Ploss A. Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles. Proceedings of the National Academy of Sciences of the United States of America. PMID 28096411 DOI: 10.1073/Pnas.1614955114 |
0.378 |
|
| 2016 |
Winer BY, Huang T, Low BE, Avery C, Pais MA, Hrebikova G, Siu E, Chiriboga L, Wiles MV, Ploss A. Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection. Virology. 502: 63-72. PMID 28006671 DOI: 10.1016/J.Virol.2016.12.017 |
0.456 |
|
| 2016 |
Ding Q, von Schaewen M, Hrebikova G, Heller B, Sandmann L, Plaas M, Ploss A. Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo. Journal of Virology. PMID 27928007 DOI: 10.1128/Jvi.01799-16 |
0.556 |
|
| 2016 |
von Schaewen M, Dorner M, Hueging K, Foquet L, Gerges S, Hrebikova G, Heller B, Bitzegeio J, Doerrbecker J, Horwitz JA, Gerold G, Suerbaum S, Rice CM, Meuleman P, Pietschmann T, ... Ploss A, et al. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation. Mbio. 7. PMID 27834208 DOI: 10.1128/Mbio.01915-16 |
0.677 |
|
| 2016 |
Li D, von Schaewen M, Wang X, Tao W, Zhang Y, Li L, Heller B, Hrebikova G, Deng Q, Ploss A, Zhong J, Huang Z. Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice. Journal of Virology. PMID 27630242 DOI: 10.1128/Jvi.01462-16 |
0.507 |
|
| 2016 |
Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology. 20: 1-10. PMID 27504999 DOI: 10.1016/J.Coviro.2016.07.009 |
0.446 |
|
| 2016 |
Bartucci M, Ferrari AC, Kim IY, Ploss A, Yarmush M, Sabaawy HE. Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice. Frontiers in Cell and Developmental Biology. 4: 64. PMID 27446916 DOI: 10.3389/Fcell.2016.00064 |
0.307 |
|
| 2016 |
von Schaewen M, Hrebikova G, Ploss A. Generation of Human Liver Chimeric Mice for the Study of Human Hepatotropic Pathogens. Methods in Molecular Biology (Clifton, N.J.). 1438: 79-101. PMID 27150085 DOI: 10.1007/978-1-4939-3661-8_5 |
0.339 |
|
| 2016 |
Winer BY, Ding Q, Gaska J, Ploss A. In vivo models of hepatitis B and C virus infection. Febs Letters. PMID 27009462 DOI: 10.1002/1873-3468.12157 |
0.556 |
|
| 2016 |
Douam F, Ding Q, Ploss A. Recent advances in understanding hepatitis C. F1000research. 5. PMID 26918166 DOI: 10.12688/F1000Research.7354.1 |
0.547 |
|
| 2016 |
Winer BY, Ploss A. Breaking the species barrier for hepatitis delta virus. Hepatology (Baltimore, Md.). 63: 334-6. PMID 26289017 DOI: 10.1002/Hep.28129 |
0.412 |
|
| 2015 |
von Schaewen M, Ploss A. Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy. Cellular and Molecular Gastroenterology and Hepatology. 1: 257-258. PMID 28210676 DOI: 10.1016/J.Jcmgh.2015.03.005 |
0.4 |
|
| 2015 |
Douam F, Gaska JM, Winer BY, Ding Q, von Schaewen M, Ploss A. Genetic Dissection of the Host Tropism of Human-Tropic Pathogens. Annual Review of Genetics. PMID 26407032 DOI: 10.1146/Annurev-Genet-112414-054823 |
0.342 |
|
| 2015 |
Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, ... ... Ploss A, et al. Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology (Baltimore, Md.). PMID 26248546 DOI: 10.1002/Hep.28111 |
0.487 |
|
| 2015 |
Ploss A, Walker C. Editorial overview: Progress and challenges in modeling human viral diseases in vivo. Current Opinion in Virology. 13: v-vii. PMID 26219570 DOI: 10.1016/J.Coviro.2015.07.004 |
0.362 |
|
| 2015 |
Winer BY, Ploss A. Determinants of hepatitis B and delta virus host tropism. Current Opinion in Virology. 13: 109-16. PMID 26164658 DOI: 10.1016/J.Coviro.2015.06.004 |
0.495 |
|
| 2015 |
Scull MA, Shi C, de Jong YP, Gerold G, Ries M, von Schaewen M, Donovan BM, Labitt RN, Horwitz JA, Gaska JM, Hrebikova G, Xiao JW, Flatley B, Fung C, Chiriboga L, ... ... Ploss A, et al. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology (Baltimore, Md.). 62: 57-67. PMID 25820364 DOI: 10.1002/Hep.27773 |
0.647 |
|
| 2015 |
Douam F, Ploss A. Proteomic approaches to analyzing hepatitis C virus biology. Proteomics. 15: 2051-65. PMID 25809442 DOI: 10.1002/Pmic.201500009 |
0.543 |
|
| 2015 |
Stoddard MB, Li H, Wang S, Saeed M, Andrus L, Ding W, Jiang X, Learn GH, von Schaewen M, Wen J, Goepfert PA, Hahn BH, Ploss A, Rice CM, Shaw GM. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4. Mbio. 6: e02518. PMID 25714714 DOI: 10.1128/Mbio.02518-14 |
0.605 |
|
| 2015 |
Siu E, Ploss A. Modeling malaria in humanized mice: opportunities and challenges. Annals of the New York Academy of Sciences. 1342: 29-36. PMID 25678404 DOI: 10.1111/Nyas.12618 |
0.333 |
|
| 2015 |
Gaska JM, Ploss A. Study of viral pathogenesis in humanized mice. Current Opinion in Virology. 11: 14-20. PMID 25618248 DOI: 10.1016/J.Coviro.2015.01.002 |
0.435 |
|
| 2015 |
Perin P, Haid S, Brown R, Schulze K, Colpitts C, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Andonyadis Y, Vondran F, Kirschning A, Schang L, Müller R, ... ... Ploss A, et al. P0674 : Clinically approved T-type calcium channel inhibitors prevent hepatitis C virus (HCV) membrane fusion in a genotype-dependent manner Journal of Hepatology. 62: S574-S575. DOI: 10.1016/S0168-8278(15)30878-3 |
0.44 |
|
| 2014 |
Ding Q, von Schaewen M, Ploss A. The impact of hepatitis C virus entry on viral tropism. Cell Host & Microbe. 16: 562-8. PMID 25525789 DOI: 10.1016/J.Chom.2014.10.009 |
0.538 |
|
| 2014 |
de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, ... ... Ploss A, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Science Translational Medicine. 6: 254ra129. PMID 25232181 DOI: 10.1126/Scitranslmed.3009512 |
0.663 |
|
| 2014 |
Ploss A. Mouse models for human infectious diseases. Journal of Immunological Methods. 410: 1-2. PMID 25017506 DOI: 10.1016/J.Jim.2014.07.002 |
0.309 |
|
| 2014 |
Billerbeck E, Labitt RN, Vega K, Frias-Staheli N, Dorner M, Xiao JW, Rice CM, Ploss A. Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice. Immunology. 143: 202-18. PMID 24766459 DOI: 10.1111/Imm.12304 |
0.491 |
|
| 2014 |
von Schaewen M, Ding Q, Ploss A. Visualizing hepatitis C virus infection in humanized mice. Journal of Immunological Methods. 410: 50-9. PMID 24642425 DOI: 10.1016/J.Jim.2014.03.006 |
0.564 |
|
| 2014 |
Sheahan T, Imanaka N, Marukian S, Dorner M, Liu P, Ploss A, Rice CM. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. Cell Host & Microbe. 15: 190-202. PMID 24528865 DOI: 10.1016/J.Chom.2014.01.007 |
0.664 |
|
| 2014 |
von Schaewen M, Ploss A. Murine models of hepatitis C: what can we look forward to? Antiviral Research. 104: 15-22. PMID 24462693 DOI: 10.1016/J.Antiviral.2014.01.007 |
0.59 |
|
| 2014 |
Frias-Staheli N, Dorner M, Marukian S, Billerbeck E, Labitt RN, Rice CM, Ploss A. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. Journal of Virology. 88: 2205-18. PMID 24335303 DOI: 10.1128/Jvi.03085-13 |
0.615 |
|
| 2014 |
Anggakusuma, Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ, Bankwitz D, Steinmann J, Ott M, Meuleman P, Rice CM, Ploss A, Pietschmann T, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 63: 1137-49. PMID 23903236 DOI: 10.1136/Gutjnl-2012-304299 |
0.644 |
|
| 2014 |
Behrendt P, Steinmann E, Kusuma A, Perin P, Menzel N, Ploss A, Meulemann P, Manns M, Pietschmann T. P233 THE NATURAL COMPOUND PENTA-O-GALLOYL-GLUCOSE, DERIVED FROM THE ROOT CORTEX MOUTAN, EFFICIENTLY INHIBITS HEPATITIS C-VIRUS ENTRY AND SHOWS EXCELLENT PHARMACOKINETIC PERFORMANCE IN VIVO Journal of Hepatology. 60: S143. DOI: 10.1016/S0168-8278(14)60395-0 |
0.343 |
|
| 2013 |
Horwitz JA, Halper-Stromberg A, Mouquet H, Gitlin AD, Tretiakova A, Eisenreich TR, Malbec M, Gravemann S, Billerbeck E, Dorner M, Büning H, Schwartz O, Knops E, Kaiser R, Seaman MS, ... ... Ploss A, et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 16538-43. PMID 24043801 DOI: 10.1073/Pnas.1315295110 |
0.494 |
|
| 2013 |
Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, Friling T, Vogt A, Catanese MT, Satoh T, Kawai T, Akira S, Law M, Rice CM, Ploss A. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature. 501: 237-41. PMID 23903655 DOI: 10.1038/Nature12427 |
0.677 |
|
| 2013 |
Billerbeck E, Horwitz JA, Labitt RN, Donovan BM, Vega K, Budell WC, Koo GC, Rice CM, Ploss A. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. Journal of Immunology (Baltimore, Md. : 1950). 191: 1753-64. PMID 23833235 DOI: 10.4049/Jimmunol.1201518 |
0.585 |
|
| 2013 |
Vogt A, Scull MA, Friling T, Horwitz JA, Donovan BM, Dorner M, Gerold G, Labitt RN, Rice CM, Ploss A. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology. 444: 1-11. PMID 23777661 DOI: 10.1016/J.Virol.2013.05.036 |
0.657 |
|
| 2013 |
Gruell H, Bournazos S, Ravetch JV, Ploss A, Nussenzweig MC, Pietzsch J. Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model. Journal of Virology. 87: 8535-44. PMID 23720722 DOI: 10.1128/Jvi.00868-13 |
0.339 |
|
| 2013 |
Guermonprez P, Helft J, Claser C, Deroubaix S, Karanje H, Gazumyan A, Darasse-Jèze G, Telerman SB, Breton G, Schreiber HA, Frias-Staheli N, Billerbeck E, Dorner M, Rice CM, Ploss A, et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nature Medicine. 19: 730-8. PMID 23685841 DOI: 10.1038/Nm.3197 |
0.536 |
|
| 2013 |
Horwitz JA, Dorner M, Friling T, Donovan BM, Vogt A, Loureiro J, Oh T, Rice CM, Ploss A. Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. Virology. 439: 23-33. PMID 23485372 DOI: 10.1016/J.Virol.2013.01.019 |
0.633 |
|
| 2013 |
Billerbeck E, de Jong Y, Dorner M, de la Fuente C, Ploss A. Animal models for hepatitis C. Current Topics in Microbiology and Immunology. 369: 49-86. PMID 23463197 DOI: 10.1007/978-3-642-27340-7_3 |
0.556 |
|
| 2013 |
Shi C, Ploss A. Hepatitis C virus vaccines in the era of new direct-acting antivirals. Expert Review of Gastroenterology & Hepatology. 7: 171-85. PMID 23363265 DOI: 10.1586/Egh.12.72 |
0.499 |
|
| 2013 |
Sandmann L, Ploss A. Barriers of hepatitis C virus interspecies transmission. Virology. 435: 70-80. PMID 23217617 DOI: 10.1016/J.Virol.2012.09.044 |
0.554 |
|
| 2013 |
Dorner M, Rice CM, Ploss A. Study of hepatitis C virus entry in genetically humanized mice. Methods (San Diego, Calif.). 59: 249-57. PMID 22687621 DOI: 10.1016/J.Ymeth.2012.05.010 |
0.672 |
|
| 2013 |
de Jong Y, Dorner M, Balazs A, Robbins J, Labitt R, Donovan B, Krishnan A, Charlton M, Chiriboga L, Burton D, Rice C, Baltimore D, Law M, Ploss A. 1146 THE EFFECTS OF BROADLY NEUTRALIZING ANTIBODIES IN EXPERIMENTAL HCV INFECTION Journal of Hepatology. 58: S466-S467. DOI: 10.1016/S0168-8278(13)61147-2 |
0.603 |
|
| 2013 |
Schwartz RE, Trehan K, Andrus L, Sheahan T, Ploss A, Duncan SA, Rice CM, Bhatia S. Mo1783 Personalizing the Study of Infectious Disease: Modeling Hepatitis C Virus Using Induced Pluripotent Stem Cells Gastroenterology. 144: S-1025. DOI: 10.1016/S0016-5085(13)63810-X |
0.564 |
|
| 2012 |
Klein F, Halper-Stromberg A, Horwitz JA, Gruell H, Scheid JF, Bournazos S, Mouquet H, Spatz LA, Diskin R, Abadir A, Zang T, Dorner M, Billerbeck E, Labitt RN, Gaebler C, ... ... Ploss A, et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature. 492: 118-22. PMID 23103874 DOI: 10.1038/Nature11604 |
0.328 |
|
| 2012 |
Vaughan AM, Mikolajczak SA, Wilson EM, Grompe M, Kaushansky A, Camargo N, Bial J, Ploss A, Kappe SH. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. The Journal of Clinical Investigation. 122: 3618-28. PMID 22996664 DOI: 10.1172/Jci62684 |
0.376 |
|
| 2012 |
Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proceedings of the National Academy of Sciences of the United States of America. 109: 14610-5. PMID 22908290 DOI: 10.1073/Pnas.1212379109 |
0.572 |
|
| 2012 |
Vaughan AM, Kappe SH, Ploss A, Mikolajczak SA. Development of humanized mouse models to study human malaria parasite infection. Future Microbiology. 7: 657-65. PMID 22568719 DOI: 10.2217/Fmb.12.27 |
0.348 |
|
| 2012 |
Ploss A, Dubuisson J. New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut. 61: i25-35. PMID 22504917 DOI: 10.1136/Gutjnl-2012-302048 |
0.534 |
|
| 2012 |
Giang E, Dorner M, Prentoe JC, Dreux M, Evans MJ, Bukh J, Rice CM, Ploss A, Burton DR, Law M. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 109: 6205-10. PMID 22492964 DOI: 10.1073/Pnas.1114927109 |
0.73 |
|
| 2012 |
Ploss A, Evans MJ. Hepatitis C virus host cell entry. Current Opinion in Virology. 2: 14-9. PMID 22440961 DOI: 10.1016/J.Coviro.2011.12.007 |
0.689 |
|
| 2012 |
Meng X, Schoggins J, Rose L, Cao J, Ploss A, Rice CM, Xiang Y. C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. Journal of Virology. 86: 4538-47. PMID 22345458 DOI: 10.1128/Jvi.06140-11 |
0.555 |
|
| 2012 |
Schwartz RE, Trehan K, Andrus L, Sheahan TP, Ploss A, Duncan SA, Rice CM, Bhatia SN. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 2544-8. PMID 22308485 DOI: 10.1073/Pnas.1121400109 |
0.606 |
|
| 2012 |
Scull MA, Ploss A. Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines. Hepatology (Baltimore, Md.). 55: 645-8. PMID 22287293 DOI: 10.1002/Hep.24716 |
0.539 |
|
| 2012 |
Vogt A, Horwitz J, Scull M, Dorner M, Gerold G, Rice C, Ploss A. 103 RECAPITULATION OF THE ENTIRE HEPATITIS C VIRUS LIFE IN ENGINEERED MOUSE CELL LINES Journal of Hepatology. 56: S46. DOI: 10.1016/S0168-8278(12)60117-2 |
0.554 |
|
| 2012 |
Schwartz R, Trehan K, Andrus L, Sheahan T, Ploss A, Duncan SA, Rice C, Bhatia S. Su1581 Modeling Hepatitis C Virus Infection Using Human Induced Pluripotent Stem Cells Gastroenterology. 142: S-971. DOI: 10.1016/S0016-5085(12)63761-5 |
0.604 |
|
| 2012 |
Ploss A. Reverse Genetic Tools to Study Hepatitis C Virus Reverse Genetics of Rna Viruses: Applications and Perspectives. 64-90. DOI: 10.1002/9781118405338.ch3 |
0.325 |
|
| 2011 |
Dorner M, Ploss A. Deconstructing hepatitis C virus infection in humanized mice. Annals of the New York Academy of Sciences. 1245: 59-62. PMID 22211981 DOI: 10.1111/J.1749-6632.2011.06317.X |
0.494 |
|
| 2011 |
Andrus L, Marukian S, Jones CT, Catanese MT, Sheahan TP, Schoggins JW, Barry WT, Dustin LB, Trehan K, Ploss A, Bhatia SN, Rice CM. Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (Baltimore, Md.). 54: 1901-12. PMID 22144107 DOI: 10.1002/Hep.24557 |
0.659 |
|
| 2011 |
Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, Rice CM, Dustin LB. Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology (Baltimore, Md.). 54: 1913-23. PMID 21800339 DOI: 10.1002/Hep.24580 |
0.647 |
|
| 2011 |
Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A. A genetically humanized mouse model for hepatitis C virus infection. Nature. 474: 208-11. PMID 21654804 DOI: 10.1038/Nature10168 |
0.68 |
|
| 2011 |
Billerbeck E, Barry WT, Mu K, Dorner M, Rice CM, Ploss A. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice. Blood. 117: 3076-86. PMID 21252091 DOI: 10.1182/Blood-2010-08-301507 |
0.517 |
|
| 2011 |
Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, Barry W, Ploss A, Rice CM, Su L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology. 140: 1334-44. PMID 21237170 DOI: 10.1053/J.Gastro.2011.01.001 |
0.667 |
|
| 2011 |
de Jong YP, Rice CM, Ploss A. Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice. Journal of Hepatology. 54: 848-50. PMID 21145816 DOI: 10.1016/J.Jhep.2010.09.034 |
0.664 |
|
| 2010 |
Gerold G, Rice CM, Ploss A. Teaching new tricks to an old foe: murinizing hepatitis C virus. Hepatology (Baltimore, Md.). 52: 2233-6. PMID 21105113 DOI: 10.1002/Hep.24045 |
0.65 |
|
| 2010 |
Sheahan T, Jones CT, Ploss A. Advances and challenges in studying hepatitis C virus in its native environment. Expert Review of Gastroenterology & Hepatology. 4: 541-50. PMID 20932139 DOI: 10.1586/Egh.10.53 |
0.547 |
|
| 2010 |
Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. Journal of Virology. 84: 6987-94. PMID 20463075 DOI: 10.1128/Jvi.00196-10 |
0.656 |
|
| 2010 |
de Jong YP, Rice CM, Ploss A. New horizons for studying human hepatotropic infections. The Journal of Clinical Investigation. 120: 650-3. PMID 20179350 DOI: 10.1172/Jci42338 |
0.623 |
|
| 2010 |
Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, Gaysinskaya VA, Mu K, Ritola K, Rice CM, Bhatia SN. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proceedings of the National Academy of Sciences of the United States of America. 107: 3141-5. PMID 20133632 DOI: 10.1073/Pnas.0915130107 |
0.653 |
|
| 2010 |
Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, Ploss A, Oh TS, Schoggins JW, MacDonald MR, Bhatia SN, Rice CM. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nature Biotechnology. 28: 167-71. PMID 20118917 DOI: 10.1038/Nbt.1604 |
0.653 |
|
| 2009 |
Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, et al. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. Journal of Immunology (Baltimore, Md. : 1950). 183: 7919-30. PMID 19933869 DOI: 10.4049/Jimmunol.0803903 |
0.513 |
|
| 2009 |
Ploss A, Rice CM. Towards a small animal model for hepatitis C. Embo Reports. 10: 1220-7. PMID 19834510 DOI: 10.1038/Embor.2009.223 |
0.648 |
|
| 2009 |
Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, Debarry J, de Jong Y, Deng H, Di Santo JP, Eisenbarth S, Eynon E, Flavell RA, Guzman CA, Huntington ND, et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host & Microbe. 6: 5-9. PMID 19616761 DOI: 10.1016/J.Chom.2009.06.006 |
0.569 |
|
| 2009 |
Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, Cohen JI, Münz C. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. The Journal of Experimental Medicine. 206: 1423-34. PMID 19487422 DOI: 10.1084/Jem.20081720 |
0.574 |
|
| 2009 |
Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 457: 882-6. PMID 19182773 DOI: 10.1038/Nature07684 |
0.754 |
|
| 2007 |
Biswas PS, Pedicord V, Ploss A, Menet E, Leiner I, Pamer EG. Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. Journal of Immunology (Baltimore, Md. : 1950). 179: 4520-8. PMID 17878348 DOI: 10.4049/Jimmunol.179.7.4520 |
0.518 |
|
| 2006 |
Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proceedings of the National Academy of Sciences of the United States of America. 103: 3805-9. PMID 16484368 DOI: 10.1073/Pnas.0511218103 |
0.778 |
|
| 2005 |
Ploss A, Leiner I, Pamer EG. Distinct regulation of H2-M3-restricted memory T cell responses in lymph node and spleen. Journal of Immunology (Baltimore, Md. : 1950). 175: 5998-6005. PMID 16237094 DOI: 10.4049/Jimmunol.175.9.5998 |
0.529 |
|
| 2005 |
Ploss A, Tran A, Menet E, Leiner I, Pamer EG. Cross-recognition of N-formylmethionine peptides is a general characteristic of H2-M3-restricted CD8+ T cells. Infection and Immunity. 73: 4423-6. PMID 15972542 DOI: 10.1128/Iai.73.7.4423-4426.2005 |
0.495 |
|
| 2004 |
Dao T, Guo D, Ploss A, Stolzer A, Saylor C, Boursalian TE, Im JS, Sant'Angelo DB. Development of CD1d-restricted NKT cells in the mouse thymus. European Journal of Immunology. 34: 3542-52. PMID 15549774 DOI: 10.1002/Eji.200425546 |
0.302 |
|
| 2004 |
Wong P, Lara-Tejero M, Ploss A, Leiner I, Pamer EG. Rapid development of T cell memory. Journal of Immunology (Baltimore, Md. : 1950). 172: 7239-45. PMID 15187098 DOI: 10.4049/Jimmunol.172.12.7239 |
0.525 |
|
| 2003 |
Ploss A, Lauvau G, Contos B, Kerksiek KM, Guirnalda PD, Leiner I, Lenz LL, Bevan MJ, Pamer EG. Promiscuity of MHC class Ib-restricted T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 171: 5948-55. PMID 14634106 DOI: 10.4049/Jimmunol.171.11.5948 |
0.632 |
|
| 2003 |
Kerksiek KM, Ploss A, Leiner I, Busch DH, Pamer EG. H2-M3-restricted memory T cells: persistence and activation without expansion. Journal of Immunology (Baltimore, Md. : 1950). 170: 1862-9. PMID 12574352 DOI: 10.4049/Jimmunol.170.4.1862 |
0.616 |
|
| 2001 |
Reuss FU, Heber R, Ploss A, Berdel B. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants Virology. 291: 91-100. PMID 11878879 DOI: 10.1006/Viro.2001.1199 |
0.419 |
|
| Show low-probability matches. |